Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01512160 · ClinicalTrials.gov registry record · Phase 2
Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain
A Phase 2 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
NCT01512160 is a Phase 2 study that was terminated before completion, run by Pfizer. The registered enrollment target is 90 participants.
The verdict
NCT01512160, a Phase 2 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the overall pain relief of a single dose of PF-04531083 against placebo following third molar extraction.
Interventions
- OTHER Placebo
- DRUG Ibuprofen
- DRUG PF-04531083
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01512160
The ClinicalTrials.gov registry entry for NCT01512160 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01512160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01512160 about?
NCT01512160 is a clinical study titled "Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain". The purpose of this study is to evaluate the overall pain relief of a single dose of PF-04531083 against placebo following third molar extraction.
What is the current status of trial NCT01512160?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2011-10. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01512160?
The interventions under investigation include: Placebo (OTHER), Ibuprofen (DRUG), PF-04531083 (DRUG).
Who is sponsoring clinical trial NCT01512160?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.